Brief: Surface Oncology - Revenue Recognized In Q4 Ended Dec 31, 2021, Was $0.2 Million, Compared To Revenue Of $87.6 Million For Same Period In 2020
02/03/2022 12:24
March 2 (Reuters) - Surface Oncology Inc SURF.O :
* SURFACE ONCOLOGY - REVENUE RECOGNIZED IN Q4 ENDED DEC 31,
2021,
WAS $0.2 MILLION, COMPARED TO REVENUE OF $87.6 MILLION FOR SAME
PERIOD IN 2020
* SURFACE ONCOLOGY INC - FOR Q4 ENDED DECEMBER 31, 2021, NET
LOSS
PER SHARE OF $0.52
* SURFACE ONCOLOGY INC - CONTINUES TO GUIDE TO CASH RUNWAY
THROUGH
2023
* SURFACE ONCOLOGY - AS OF DEC 31, 2021, CASH, CASH
EQUIVALENTS
AND MARKETABLE SECURITIES WERE $154.1 MILLION , COMPARED TO
$175.1 MILLION ON DEC 31, 2020
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Surface Oncology
See all newsBrief: Surface Oncology Says Anticipates Will Have Net Cash Of $20 Million To $25 Million At The Closing Of The Proposed Mergers
Surface Oncology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Surface Oncology, Inc. Q2 Net Income USD -28.2 Mln
Surface Oncology Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: ADAR1 Partners Reports 5.24% Passive Stake In Surface Oncology Inc As Of July 10 - SEC Filing